Alteration of serum thymus and activation-regulated chemokine level during biologic therapy for psoriasis: Possibility as a marker reflecting favorable response to anti-interleukin-17A agents.

IR

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top